Literature DB >> 24737501

Watching, but not waiting: vascular neurology perspective on the disparate regulatory pathways for stroke.

Sunil A Sheth1, Raul G Nogueira2, Ali Reza Noorian1, David S Liebeskind1.   

Abstract

Entities:  

Keywords:  Device; Economics; History; Stroke; Thrombectomy

Mesh：

Year:  2014        PMID： 24737501      PMCID： PMC4198506          DOI： 10.1136/neurintsurg-2014-011146

Source DB:  PubMed          Journal:  J Neurointerv Surg        ISSN： 1759-8478            Impact factor:   5.836


× No keyword cloud information.
  16 in total

1.  A comparison of reteplase with alteplase for acute myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1997-10-16       Impact factor: 91.245

2.  A comparison of continuous infusion of alteplase with double-bolus administration for acute myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1997-10-16       Impact factor: 91.245

3.  Endovascular treatment for acute ischemic stroke--still unproven.

Authors:  Marc I Chimowitz
Journal:  N Engl J Med       Date:  2013-02-08       Impact factor: 91.245

4.  Relationship of stroke to other cardiovascular disease.

Authors:  G D Friedman; D B Loveland; S P Ehrlich
Journal:  Circulation       Date:  1968-09       Impact factor: 29.690

5.  Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial.

Authors:  E J Topol
Journal:  Lancet       Date:  2001-06-16       Impact factor: 79.321

6.  Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial.

Authors:  F Van De Werf; J Adgey; D Ardissino; P W Armstrong; P Aylward; G Barbash; A Betriu; A S Binbrek; R Califf; R Diaz; R Fanebust; K Fox; C Granger; J Heikkilä; S Husted; P Jansky; A Langer; E Lupi; A Maseri; J Meyer; J Mlczoch; D Mocceti; D Myburgh; A Oto; E Paolasso; K Pehrsson; R Seabra-Gomes; L Soares-Piegas; D Sùgrue; M Tendera; E Topol; P Toutouzas; A Vahanian; F Verheugt; L Wallentin; H White
Journal:  Lancet       Date:  1999-08-28       Impact factor: 79.321

7.  Bivalirudin for patients with acute coronary syndromes.

Authors:  Gregg W Stone; Brent T McLaurin; David A Cox; Michel E Bertrand; A Michael Lincoff; Jeffrey W Moses; Harvey D White; Stuart J Pocock; James H Ware; Frederick Feit; Antonio Colombo; Philip E Aylward; Angel R Cequier; Harald Darius; Walter Desmet; Ramin Ebrahimi; Martial Hamon; Lars H Rasmussen; Hans-Jürgen Rupprecht; James Hoekstra; Roxana Mehran; E Magnus Ohman
Journal:  N Engl J Med       Date:  2006-11-23       Impact factor: 91.245

8.  Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study.

Authors:  P A Wolf; R D Abbott; W B Kannel
Journal:  Arch Intern Med       Date:  1987-09

9.  Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.

Authors:  Patrick W Serruys; Marie-Claude Morice; A Pieter Kappetein; Antonio Colombo; David R Holmes; Michael J Mack; Elisabeth Ståhle; Ted E Feldman; Marcel van den Brand; Eric J Bass; Nic Van Dyck; Katrin Leadley; Keith D Dawkins; Friedrich W Mohr
Journal:  N Engl J Med       Date:  2009-02-18       Impact factor: 91.245

10.  Influence of etiology of atrial fibrillation on incidence of systemic embolism.

Authors:  R C Hinton; J P Kistler; J T Fallon; A L Friedlich; C M Fisher
Journal:  Am J Cardiol       Date:  1977-10       Impact factor: 2.778
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.